Key result
Transcriptome profiling of human cardiac stromal cells identified 3 miRNAs and 272 genes as significantly differentially expressed between arrhythmogenic cardiomyopathy patients and healthy controls.
Case-Control (n=15)
No
p-value: p=<0.05
Identified a specific coding and non-coding transcriptome profile in cardiac stromal cells of ACM patients, highlighting the potential role of miR-29b-3p in disease pathogenesis.
Hypothesis-generating for ACM mechanisms in stromal cells; leaves open clinical translation pending validation.
BACKGROUND: Arrhythmogenic cardiomyopathy (ACM) is a genetic autosomal disease characterized by abnormal cell-cell adhesion, cardiomyocyte death, progressive fibro-adipose replacement of the myocardium, arrhythmias and sudden death. Several different cell types contribute to the pathogenesis of ACM, including, as recently described, cardiac stromal cells (CStCs). In the present study, we aim to identify ACM-specific expression profiles of human CStCs derived from endomyocardial biopsies of ACM patients and healthy individuals employing TaqMan Low Density Arrays for miRNA expression profiling, and high throughput sequencing for gene expression quantification. RESULTS: We identified 3 miRNAs and 272 genes as significantly differentially expressed at a 5% false discovery rate. Both the differentially expressed genes as well as the target genes of the ACM-specific miRNAs were found to be enriched in cell adhesion-related biological processes. Functional similarity and protein interaction-based network analyses performed on the identified deregulated genes, miRNA targets and known ACM-causative genes revealed clusters of highly related genes involved in cell adhesion, extracellular matrix organization, lipid transport and ephrin receptor signaling. CONCLUSIONS: We determined for the first time the coding and non-coding transcriptome characteristic of ACM cardiac stromal cells, finding evidence for a potential contribution of miRNAs, specifically miR-29b-3p, to ACM pathogenesis or phenotype maintenance.
No takes yet. Share an insight, caveat, or question.
Rainer et al. (2018) conducted a case-control in Arrhythmogenic cardiomyopathy (n=15). Arrhythmogenic cardiomyopathy vs. Healthy controls was evaluated on Differentially expressed miRNAs and genes (p=<0.05). Transcriptome profiling of human cardiac stromal cells identified 3 miRNAs and 272 genes as significantly differentially expressed between arrhythmogenic cardiomyopathy patients and healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: